Bristol-Myers Squibb Company
BMY
$45.94
$0.150.33%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 48.03B | 47.70B | 47.64B | 48.30B | 47.44B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.03B | 47.70B | 47.64B | 48.30B | 47.44B |
| Cost of Revenue | 12.90B | 12.44B | 12.06B | 11.95B | 11.44B |
| Gross Profit | 35.14B | 35.26B | 35.58B | 36.35B | 35.99B |
| SG&A Expenses | 6.91B | 7.20B | 7.43B | 7.82B | 8.03B |
| Depreciation & Amortization | 4.18B | 5.76B | 7.35B | 8.87B | 9.46B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.71B | 35.04B | 36.51B | 38.42B | 38.40B |
| Operating Income | 14.32B | 12.66B | 11.13B | 9.88B | 9.03B |
| Income Before Tax | 8.03B | 6.59B | 6.11B | -8.38B | -6.88B |
| Income Tax Expenses | 1.99B | 1.53B | 671.00M | 554.00M | 367.00M |
| Earnings from Continuing Operations | 6.05K | 5.07K | 5.44K | -8.93K | -7.25K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -6.00M | -16.00M | -18.00M | -15.00M | -11.00M |
| Net Income | 6.04B | 5.05B | 5.42B | -8.95B | -7.26B |
| EBIT | 14.32B | 12.66B | 11.13B | 9.88B | 9.03B |
| EBITDA | 19.23B | 19.16B | 19.22B | 19.45B | 19.21B |
| EPS Basic | 2.97 | 2.49 | 2.67 | -4.43 | -3.59 |
| Normalized Basic EPS | 4.44 | 3.92 | 3.44 | 3.07 | 3.04 |
| EPS Diluted | 2.96 | 2.47 | 2.66 | -4.43 | -3.60 |
| Normalized Diluted EPS | 4.43 | 3.91 | 3.44 | 3.06 | 3.04 |
| Average Basic Shares Outstanding | 8.13B | 8.12B | 8.12B | 8.11B | 8.11B |
| Average Diluted Shares Outstanding | 8.15B | 8.15B | 8.14B | 8.12B | 8.12B |
| Dividend Per Share | 2.48 | 2.46 | 2.44 | 2.42 | 2.40 |
| Payout Ratio | 82.81% | 98.12% | 90.59% | -54.35% | -66.20% |